• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Madison Small And The Threat Of Bacterial Meningitis
Eighteen-year old high school student Madison Small of Ashburn, Virginia is dead after a swift and unexpected bacterial infection, reported ABC News. Small, an accomplished softball player, complained of a headache on the evening of Monday, Apr. 6 and was taken to the hospital, according to local news station WJLA in the video above. She died the next morning. On April 13, health investigators announced that she had died of bacterial meningitis, but said that her case was not part of a wider outbreak in the community. Bacterial meningitis is rare but severe. The infection, which can be caused by several different strai...
Source: Science - The Huffington Post - April 13, 2015 Category: Science Source Type: news